Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.39 - $6.36 $59,901 - $86,782
-13,645 Reduced 75.76%
4,367 $20,000
Q1 2024

May 13, 2024

SELL
$5.3 - $7.61 $3.56 Million - $5.11 Million
-670,910 Reduced 97.39%
18,012 $102,000
Q4 2023

Feb 09, 2024

BUY
$4.5 - $7.51 $3.05 Million - $5.09 Million
677,933 Added 6169.2%
688,922 $4.56 Million
Q3 2023

Nov 09, 2023

BUY
$7.85 - $10.68 $14,043 - $19,106
1,789 Added 19.45%
10,989 $87,000
Q2 2023

Aug 11, 2023

BUY
$9.23 - $11.23 $76,295 - $92,827
8,266 Added 885.01%
9,200 $93,000
Q1 2023

May 12, 2023

SELL
$9.41 - $12.03 $23,308 - $29,798
-2,477 Reduced 72.62%
934 $9,000
Q4 2022

Feb 08, 2023

BUY
$6.5 - $11.5 $858 - $1,518
132 Added 4.03%
3,411 $39,000
Q3 2022

Nov 10, 2022

BUY
$7.36 - $9.15 $8,787 - $10,925
1,194 Added 57.27%
3,279 $28,000
Q2 2022

Aug 10, 2022

BUY
$5.54 - $11.49 $5,279 - $10,949
953 Added 84.19%
2,085 $15,000
Q1 2022

May 16, 2022

SELL
$11.35 - $13.7 $132,987 - $160,522
-11,717 Reduced 91.19%
1,132 $13,000
Q4 2021

Feb 14, 2022

SELL
$11.95 - $13.34 $8,878 - $9,911
-743 Reduced 5.47%
12,849 $164,000
Q3 2021

Nov 15, 2021

BUY
$12.2 - $15.93 $2,879 - $3,759
236 Added 1.77%
13,592 $186,000
Q2 2021

Aug 13, 2021

SELL
$11.7 - $16.11 $16,181 - $22,280
-1,383 Reduced 9.38%
13,356 $215,000
Q1 2021

May 12, 2021

BUY
$12.84 - $17.26 $4,070 - $5,471
317 Added 2.2%
14,739 $220,000
Q4 2020

Feb 11, 2021

SELL
$14.61 - $17.59 $43,333 - $52,171
-2,966 Reduced 17.06%
14,422 $217,000
Q3 2020

Nov 12, 2020

SELL
$11.64 - $16.86 $9,940 - $14,398
-854 Reduced 4.68%
17,388 $288,000
Q2 2020

Jul 31, 2020

BUY
$7.75 - $22.61 $15,972 - $46,599
2,061 Added 12.74%
18,242 $236,000
Q4 2019

Feb 14, 2020

BUY
$11.26 - $13.8 $182,198 - $223,297
16,181 New
16,181 $210,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $51.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.